2TY-18367-99200
2 vaccinations
2 coded responses
21 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 501 / IA
- Registered
- 2021-12-17
- Relationship
- Child or adolescent in my care
- Guardian
- 43U-12497-47989
- Race
- American Indian or Alaska Native
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-14
Dose 1 — Pfizer-BioNTech
-
2021-12-17
Registered in v-safe
-
2021-12-17
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fever · Joint painsAdult check-in
- 2021-12-18
- 2021-12-19
- 2021-12-20
- 2021-12-23
- 2021-12-28
- 2022-01-13
-
2022-01-14
Dose 2 — Pfizer-BioNTech
-
2022-01-15
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2022-01-16
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-01-17
- 2022-01-19
- 2022-01-20
- 2022-01-21
- 2022-01-30
- 2022-02-04
- 2022-02-13
- 2022-02-20
- 2022-02-25
-
2022-04-15
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Diarrhoea, Influenza, Nasopharyngitis, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative, Vomiting — Feeling: GoodFree text: Flu (fever, vomiting, diarrhea) and a week later a cold with runny nose, congestion, and cough. At home COVID tests were negative both weeks.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-17
-
2023-01-16
Survey response — 12 months, dose 2, dependentMedDRA: Cough, Diarrhoea, Pyrexia, Rash, Rhinorrhoea, Viral infection, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-14 | Pfizer-BioNTech | No |
| 2 | 2022-01-14 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 2, dependent
Symptoms: Flu (fever, vomiting, diarrhea) and a week later a cold with runny nose, congestion, and cough. At home COVID tests were negative both weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release